These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14610236)

  • 1. Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release.
    von Aulock S; Boneberg EM; Diterich I; Hartung T
    J Pharmacol Exp Ther; 2004 Feb; 308(2):754-9. PubMed ID: 14610236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions.
    Hartung T; Doecke WD; Bundschuh D; Foote MA; Gantner F; Hermann C; Lenz A; Milwee S; Rich B; Simon B; Volk HD; von Aulock S; Wendel A
    Clin Pharmacol Ther; 1999 Oct; 66(4):415-24. PubMed ID: 10546926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-alpha formation.
    Hareng L; Meergans T; von Aulock S; Volk HD; Hartung T
    Eur J Immunol; 2003 Aug; 33(8):2287-96. PubMed ID: 12884304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
    Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
    Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of carbohydrate moiety in granulocyte colony stimulating factor.
    Sakagami H; Tajima M; Takayama F; Oi T; Kusama K; Yamamoto T; Saito M; Murayama J
    Anticancer Res; 2000; 20(4):2355-9. PubMed ID: 10953296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
    Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
    Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
    Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte colony stimulating factor treatment on ex vivo cytokine production by blood cells of patients after chemotherapy or radiotherapy.
    Kamińska T; Dmoszyńska A; Hus I; Croneck AW; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):61-5. PubMed ID: 11729831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of granulocyte colony-stimulating factor on neutrophils and inflammatory cytokines in the early stage of severe acute pancreatitis in rats.
    Tuo H; Sugiyama M; Nakashima M; Abe N; Atomi Y
    J Gastroenterol; 2005 Feb; 40(2):186-91. PubMed ID: 15770403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma.
    Boneberg EM; Hareng L; Gantner F; Wendel A; Hartung T
    Blood; 2000 Jan; 95(1):270-6. PubMed ID: 10607712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
    Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
    Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor decreases tumor necrosis factor production in whole blood: role of interleukin-10 and prostaglandin E(2).
    Agnello D; Mascagni P; Bertini R; Villa P; Senaldi G; Ghezzi P
    Eur Cytokine Netw; 2004; 15(4):323-6. PubMed ID: 15627641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.